Published in Immunogenetics on July 10, 2017
Foreword: Immunogenetics special issue 2017. Immunogenetics (2017) 0.75
Cancer-related inflammation. Nature (2008) 34.21
Signatures of mutational processes in human cancer. Nature (2013) 21.63
Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science (2002) 9.17
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science (1999) 8.11
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature (1998) 7.12
A statistical method for predicting classical HLA alleles from SNP data. Am J Hum Genet (2008) 4.65
Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol (2011) 4.31
Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol (1994) 4.29
Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics (2008) 4.25
Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet (2005) 4.23
Schizophrenia risk from complex variation of complement component 4. Nature (2016) 3.84
Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature (1993) 3.65
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med (2015) 3.29
Influence of HLA-C expression level on HIV control. Science (2013) 3.27
Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity (1996) 2.93
Pathways of antigen processing. Annu Rev Immunol (2013) 2.82
Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature (2012) 2.46
Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci U S A (2000) 2.40
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat Rev Cancer (2014) 2.27
MHC class I: an unexpected role in neuronal plasticity. Neuron (2009) 2.20
Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature (1992) 2.12
Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat Immunol (2010) 2.08
Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity (2002) 2.02
A new human HLA class II-related locus, DM. Nature (1991) 1.91
Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity (2003) 1.89
Major histocompatibility complex genomics and human disease. Annu Rev Genomics Hum Genet (2013) 1.75
Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci U S A (2010) 1.72
Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev (1999) 1.65
A critical look at HLA-G. Trends Immunol (2008) 1.55
A large fraction of HLA class I ligands are proteasome-generated spliced peptides. Science (2016) 1.51
The nature of the MHC class I peptide loading complex. Immunol Rev (1999) 1.48
Inheritable variable sizes of DNA stretches in the human MHC: conserved extended haplotypes and their fragments or blocks. Tissue Antigens (2003) 1.46
Control of antigen presentation by a single protease cleavage site. Immunity (2000) 1.45
IRAP identifies an endosomal compartment required for MHC class I cross-presentation. Science (2009) 1.43
Altered antigen presentation in mice lacking H2-O. Immunity (1998) 1.36
A closer look at proteolysis and MHC-class-II-restricted antigen presentation. Curr Opin Immunol (2002) 1.32
Unconventional recognition of peptides by T cells and the implications for autoimmunity. Nat Rev Immunol (2012) 1.29
HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism. Nat Struct Mol Biol (2012) 1.25
Immunogenetics of HIV disease. Immunol Rev (2013) 1.25
Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2. J Immunol (2003) 1.22
Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection. Cell (2012) 1.21
Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface. Proc Natl Acad Sci U S A (2005) 1.20
The human HLA class II alpha chain gene DZ alpha is distinct from genes in the DP, DQ and DR subregions. EMBO J (1985) 1.17
Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens. Nat Rev Drug Discov (2015) 1.14
The urgent need to recover MHC class I in cancers for effective immunotherapy. Curr Opin Immunol (2016) 1.11
Does the immune system naturally protect against cancer? Front Immunol (2014) 1.02
Strategies to counteract MHC-I defects in tumors. Curr Opin Immunol (2011) 1.02
How selective is the transporter associated with antigen processing? Immunity (1996) 1.01
Regulation of MHC class II antigen presentation by sorting of recycling HLA-DM/DO and class II within the multivesicular body. J Immunol (2001) 1.00
CIIV, MIIC and other compartments for MHC class II loading. Eur J Immunol (1999) 0.95
Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset. PLoS Pathog (2015) 0.93
HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation. Curr Opin Immunol (2013) 0.92
Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat Genet (2015) 0.91
Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation. FASEB J (1995) 0.90
A bird's eye view of NK cell receptor interactions with their MHC class I ligands. Immunol Rev (2015) 0.88
Exclusive expression of proteasome subunit {beta}5t in the human thymic cortex. Blood (2009) 0.88
Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames. Nat Commun (2016) 0.88
Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding. Elife (2015) 0.88
Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing. Am J Hum Genet (2016) 0.87
Modest cortex and promiscuous medulla for thymic repertoire formation. Trends Immunol (2008) 0.86
HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1. PLoS One (2016) 0.85
TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst. Elife (2015) 0.84
HLA antigen expression in melanocytic lesions: is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes? J Am Acad Dermatol (2012) 0.83
Sibling rivalry: competition between MHC class II family members inhibits immunity. Nat Struct Mol Biol (2013) 0.83
Adrenal 21-hydroxylase cytochrome P-450 genes within the MHC class III region. Immunol Rev (1985) 0.82
Genetics of narcolepsy and other sleep disorders. Am J Hum Genet (1997) 0.81
Very long haplotype tracts characterized at high resolution from HLA homozygous cell lines. Immunogenetics (2015) 0.81
Molecular mechanism of peptide editing in the tapasin-MHC I complex. Sci Rep (2016) 0.80
Variations in MHC Class II Antigen Processing and Presentation in Health and Disease. Annu Rev Immunol (2016) 0.79
Class I HLA haplotypes form two schools that educate NK cells in different ways. Sci Immunol (2016) 0.79
The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key? J Cancer Res Clin Oncol (2012) 0.78
HLA-DMA polymorphisms differentially affect MHC class II peptide loading. J Immunol (2014) 0.78
ERAP1-ERAP2 dimers trim MHC I-bound precursor peptides; implications for understanding peptide editing. Sci Rep (2016) 0.78
MHC class I-associated peptides derive from selective regions of the human genome. J Clin Invest (2016) 0.77
MHC class II complexes sample intermediate states along the peptide exchange pathway. Nat Commun (2016) 0.76
Innate and adaptive genetic pathways in HCV infection. Tissue Antigens (2015) 0.76
pH-susceptibility of HLA-DO tunes DO/DM ratios to regulate HLA-DM catalytic activity. Sci Rep (2015) 0.76
Tumors with a more complex genome have a higher frequency of HLA class I total loss: a unifying pan-cancer hypothesis. Tissue Antigens (2014) 0.76
Excess of Deleterious Mutations around HLA Genes Reveals Evolutionary Cost of Balancing Selection. Mol Biol Evol (2016) 0.75